Zuccalà A, Zucchelli P. Is nephroangiosclerosis a hypertension-induced nephropathy? Contrib Nephrol. 1996;119:110–4.

Article  Google Scholar 

Meyrier A. Nephrosclerosis: a term in quest of a disease. Nephron 2015;129:276–82.

Article  Google Scholar 

Kramer A, Pippias M, Noordzij M, Stel VS, Andrusev AM, Aparicio-Madre MI, et al. The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: A summary. Clin Kidney J. 2019;12:702–20.

Article  Google Scholar 

Cianci R, Barbano B, Martina P, Gigante A, Polidori L, Lai S, et al. Nephroangiosclerosis and its pharmacological approach. Curr Vasc Pharm. 2011;9:238–43.

Article  Google Scholar 

Zaza G, Bernich P, Lupo A. ‘Triveneto’ Register of Renal Biopsies (TVRRB). Renal biopsy in chronic kidney disease: Lessons from a large Italian registry. Am J Nephrol. 2013;37:255–63.

Article  Google Scholar 

Moutzouris DA, Herlitz L, Appel GB, Markowitz GS, Freudenthal B, Radhakrishnan J, et al. Renal biopsy in the very elderly. Clin J Am Soc Nephrol. 2009;4:1073–82.

Article  Google Scholar 

Øvrehus MA, Oldereid TS, Dadfar A, Bjørneklett R, Aasarød KI, Fogo AB, et al. Clinical phenotypes and long-term prognosis in white patients with biopsy-verified hypertensive nephrosclerosis. Kidney Int Rep. 2019;5:339–47.

Article  Google Scholar 

Hallan SI, Øvrehus MA, Bjørneklett R, Aasarød KI, Fogo AB, Ix JH. Hypertensive nephrosclerosis: wider kidney biopsy indications may be needed to improve diagnostics. J Intern Med. 2021;289:69–83.

Article  Google Scholar 

Lusco MA, Najafian B, Alpers CE, Fogo AB. AJKD Atlas of Renal Pathology: Arterionephrosclerosis. Am J Kidney Dis. 2016;67:e21–2.

Article  Google Scholar 

Liang S, Le W, Liang D, Chen H, Xu F, Chen H, et al. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: A retrospective cohort study. BMC Nephrol. 2016;17:42.

Article  Google Scholar 

Koomans HA, Joles JA, Rabelink TJ. Tony Raine Memorial Lecture. Hypertension and the kidney: Culprit and victim. Nephrol Dial Transpl. 1996;11:1961–6.

Article  Google Scholar 

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;2018:3021–104.

Article  Google Scholar 

Stiles KP, Yuan CM, Chung EM, Lyon RD, Lane JD, Abbott KC. Renal biopsy in high-risk patients with medical diseases of the kidney. Am J Kidney Dis. 2000;36:419–33.

Article  Google Scholar 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.

Article  Google Scholar 

Parolini C, Noce A, Staffolani E, Giarrizzo GF, Costanzi S, Splendiani G. Renal resistive index and long-term outcome in chronic nephropathies. Radiology 2009;252:888–96.

Article  Google Scholar 

Wang G, Lai FM, Kwan BC, Lai KB, Chow KM, Li PK, et al. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens. 2009;22:300–6.

Article  Google Scholar 

Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int. 1997;51:244–52.

Article  Google Scholar 

Zucchelli P, Zuccalà A. Recent data on hypertension and progressive renal disease. J Hum Hypertens. 1996;10:679–82.

Google Scholar 

Meyrier A. Nephrosclerosis: A term in quest of a disease. Nephron 2015;129:276–82.

Article  Google Scholar 

Sumida K, Takeda A, Furuichi K, Uesugi N, Ubara Y, Sato H, et al. Clinicopathological discordance in biopsy-proven nephrosclerosis: A nationwide cross-sectional study of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2022;26:325–32.

Article  Google Scholar 

Tracy RE, Ishii T. What is ‘nephrosclerosis’? lessons from the US, Japan, and Mexico. Nephrol Dial Transpl. 2000;15:1357–66.

Article  Google Scholar 

Guyton AC, Coleman TG, Cowley AV Jr, Scheel KW, Manning RD Jr, Norman RA Jr, et al. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med. 1972;52:584–94.

Article  Google Scholar 

Marín R, Gorostidi M, Fernández-Vega F, Alvarez-Navascués R. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Kidney Int Suppl. 2005:S52–6. https://doi.org/10.1111/j.1523-1755.2005.09910.x.

Zuccala’ A, Cianci R, Presta P, Fuiano G. Nephroangiosclerosis and ischemic nephropathy: two different entities or two renal manifestations of the same systemic cardiovascular disease? G Ital Nefrol. 2009;26:299–309.

Google Scholar 

Haitsma Mulier JLG, Rozemeijer S, Röttgering JG, Spoelstra-de Man AME, Elbers PWG, Tuinman PR. et al. Renal resistive index as an early predictor and discriminator of acute kidney injury in critically ill patients; A prospective observational cohort study. PLoS One. 2018;13:e0197967

Article  Google Scholar 

Tublin ME, Bude RO, Platt JF. The resistive index in renal Doppler sonography: where do we stand? AJR Am J Roentgenol. 2003;180:885–92.

Article  Google Scholar 

Gigante A, Perrotta AM, De Marco O, Rosato E, Lai S, Cianci R. Sonographic evaluation of hypertension: Role of atrophic index and renal resistive index. J Clin Hypertens (Greenwich). 2022;24:955–7.

Article  Google Scholar 

Gigante A, Barbano B, Di Mario F, Rosato E, Simonelli M, Rocca AR, et al. Renal parenchymal resistance in patients with biopsy proven glomerulonephritis: Correlation with histological findings. Int J Immunopathol Pharm. 2016;29:469–74.

Article  Google Scholar 

Gigante A, Giannakakis K, Di Mario F, Barbano B, Rosato E, Pofi R, et al. BMI, nephroangiosclerosis and glomerulonephritis: Is there any meeting point? Nephrol (Carlton). 2018;23:991–6.

Article  Google Scholar